Answers are grounded in this paper and cite their sources.
Cross-sectional study finds high rates of anxiety and depression linked to lingering symptoms in recovered COVID-19 patients, highlighting the need for routine psychological follow-up.
Prevalence of anxiety or depression was investigated in 105 coronavirus disease 2019 (COVID-19) patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale (HADS-A/D). 30% of patients displayed pathological HADS-A/D, 52.4% showed persistent symptoms. Pathological patients with HADS-A/D more commonly reported symptom persistence, even after adjustment for age, gender, and disease severity. Psychological assessments should be encouraged in COVID-19 patients' follow-up.
No takes yet. Share an insight, caveat, or question.
Tomasoni et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: